(Q27255809)
Statements
652.352±0 dalton
1 reference
Capreomycin IB (English)
14 October 2016
C₂₅H₄₄N₁₄O₇
1 reference
Capreomycin IB (English)
14 October 2016
CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(CCCN)N
1 reference
Capreomycin IB (English)
14 October 2016
C[C@H]1C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCN=C(N2)N)CNC(=O)C[C@H](CCCN)N
1 reference
Capreomycin IB (English)
14 October 2016
Identifiers
1 reference
Capreomycin IB (English)
14 October 2016
1 reference
Capreomycin IB (English)
14 October 2016
1 reference
capreomycin ib (English)
14 October 2016
1 reference
(3S)-3,6-Diamino-N-({(2S,5S,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl]-8-[(carbamoylamino)methylene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl} (English)
14 October 2016
2 references
Capreomycin IB (English)
14 October 2016
2 references
capreomycin ib (English)
14 October 2016